-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, JfKnuualaKeolpEIuCmfO4cxgkOkNVJrNSYhlGjWi1Y8AgEwvIq+EwcjnUErlCrS q+JHxIcEZfqyrlPXseFmrg== 0001192482-09-000095.txt : 20090413 0001192482-09-000095.hdr.sgml : 20090413 20090413150926 ACCESSION NUMBER: 0001192482-09-000095 CONFORMED SUBMISSION TYPE: D/A PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506 FILED AS OF DATE: 20090413 DATE AS OF CHANGE: 20090413 EFFECTIVENESS DATE: 20090413 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Diasome Pharmaceuticals LLC CENTRAL INDEX KEY: 0001411617 IRS NUMBER: 000000000 STATE OF INCORPORATION: PA FILING VALUES: FORM TYPE: D/A SEC ACT: 1933 Act SEC FILE NUMBER: 021-108333 FILM NUMBER: 09746508 BUSINESS ADDRESS: STREET 1: 625 Ridge Pike STREET 2: Suite E-402 CITY: Conshohocken STATE: PA ZIP: 19428 MAIL ADDRESS: STREET 1: 625 Ridge Pike STREET 2: Suite E-402 CITY: Conshohocken STATE: PA ZIP: 19428 D/A 1 primary_doc.xml X0301 D/A LIVE 0001411617 Diasome Pharmaceuticals LLC 625 Ridge Pike Suite 402 Conshohocken PA 19428 610.923.9443 None PA Limited Liability Company true 2008 Len Rosenberg 625 Ridge Pike, Suite 402 Conshohocken PA 19428 Executive Officer Director Robert Geho 625 Ridge Pike, Suite 402 Conshohocken PA 19428 Executive Officer W. Blair Geho 625 Ridge Pike, Suite 402 Conshohocken PA 19428 Executive Officer Director Brenda Gavin c/o Quaker Bioventures Cira Center, 2929 Arch Street Philadelphia PA 19104 Director Devang Kantesaria 1400 Liberty Ridge Drive, Suite 103 Wayne PA 19087 Director Richard Caruso c/o Provco Group 795 E. Lancaster Avenue, Suite 200 Villanova PA 19085 Director Pharmaceuticals Decline to Disclose 06 true 9999999997-08-021146 2008-03-27 false true true false 13752 13400000 12900000 500000 false 9 0 0 0 false Diasome Pharmaceuticals LLC Len Rosenberg Len Rosenberg President 2009-04-10 -----END PRIVACY-ENHANCED MESSAGE-----